Xie Jian's Form 4 filing
Fulgent Genetics, Inc. (FLGT) · filed Dec 13, 2023
- Accession no.
- 0001209191-23-058570
- Filed
- Dec 13, 2023
- Trade date
- Dec 11, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $583.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Xie JianCIK 0001819718 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | SSaleDisposed | −10,000 | $26.32 | −$263,200 | 375,124 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −12,000 | $26.69 | −$320,280 | 363,124 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.